|
Vinblastine Sulfate
Vincaleukoblastine, sulfate (1:1) (salt). Vincaleukoblastine sulfate (1:1) (salt) » Vinblastine Sulfate contains not less than 96.0 percent and not more than 102.0 percent of C46H58N4O9·H2SO4, corrections being applied for loss in weight.
CautionHandle Vinblastine Sulfate with great care, because it is a potent cytotoxic agent.
Packaging and storage
Preserve in tight, light-resistant containers, in a freezer.
Labeling
Where it is intended for use in preparing injectable dosage forms, the label states that it is sterile or must be subjected to further processing during the preparation of injectable dosage forms.
USP Reference standards
USP Endotoxin RS. USP Vinblastine Sulfate RS. USP Vincristine Sulfate RS. [noteNo Loss on drying determination is needed for USP Vincristine Sulfate RS.]
Identification
A:
Infrared Absorption
B:
A solution (1 in 10) responds to the test for Sulfate
pH
Loss on drying
(see Thermal Analysis
Related compounds
Mobile phase
, System suitability preparation, and Chromatographic systemPrepare as directed in the Assay.
Low load test preparation
Pipet 1 mL of High load test preparation into a 25-mL volumetric flask, dilute with water to volume, and mix.
Procedure
Separately inject 200 µL of the Low load test preparation and of the High load test preparation into the chromatograph, and record the chromatograms. Measure the peak responses, ri, of any related substances appearing after the solvent peak in the chromatogram of the High load test preparation. Calculate the total percentage of responses due to related substances taken by the formula:
100rt / (rt + 25rv)
in which rt is the sum of the ri responses; and rv is the vinblastine peak response in the chromatogram of the Low load test preparation. Not more than 3.0% is found. Calculate the percentage response of each related substance taken by the formula:
100ri / (rt + 25rv).
Not more than 1.0% of response due to any individual related substance is found.
Other requirements
Where the label states that Vinblastine Sulfate is sterile, it meets the requirements for Sterility and Bacterial endotoxins under Vinblastine Sulfate for Injection. Where the label states that Vinblastine Sulfate must be subjected to further processing during the preparation of injectable dosage forms, it meets the requirements for Bacterial endotoxins under Vinblastine Sulfate for Injection.
Assay
Mobile phase
Mix 14 mL of diethylamine with 986 mL of water, and adjust with phosphoric acid to a pH of 7.5 (Solution A). Mix 200 mL of acetonitrile with 800 mL of methanol (Solution B). Mix 380 mL of Solution A with 620 mL of Solution B, pass through a 0.5-µm filter, and degas under vacuum. The ratio of Solutions A and B may be varied to meet system suitability requirements and to provide a suitable elution time for vinblastine sulfate.
Standard preparation
Dissolve an accurately weighed quantity of USP Vinblastine Sulfate RS in water to obtain a solution having a known concentration of about 0.4 mg per mL.
Assay preparation
Transfer about 4 mg of Vinblastine Sulfate, accurately weighed, to a 10-mL volumetric flask, dissolve in and dilute with water to volume, and mix.
System suitability preparation
Dissolve an amount of USP Vincristine Sulfate RS in a portion of Standard preparation to obtain a solution having concentrations of about 0.4 mg of each Reference Standard per mL.
Chromatographic system
(see Chromatography
Procedure
Separately inject equal volumes (about 20 µL) of the Standard preparation and the Assay preparation into the chromatograph, record the chromatograms, and measure the responses for the major peaks. Calculate the quantity, in mg, of C46H58N4O9·H2SO4 in the portion of Vinblastine Sulfate taken by the formula:
10C(rU / rS)
in which C is the concentration, in mg per mL, of USP Vinblastine Sulfate RS (corrected for loss in weight) in the Standard preparation; and rU and rS are the peak responses obtained from the Assay preparation and the Standard preparation, respectively.
Auxiliary Information
Please check for your question in the FAQs before contacting USP.
Chromatographic Column
USP32NF27 Page 3859
Pharmacopeial Forum: Volume No. 32(5) Page 1470
Chromatographic columns text is not derived from, and not part of, USP 32 or NF 27.
|